{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:03:43Z","timestamp":1781625823076,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The cannabinoid receptor (CB) signal transduction is a complex system that is relatively widespread in mammalian cells and tissues. By regulating the local levels and actions of other chemical signals, it can activate multiple cascades in different organs. Cannabinoid receptors and endocannabinoids are also present in the human lower urinary tract (LUT) and genital tract, including the urinary bladder, prostate, urethra, penile erectile tissue and seminal vesicles. The present review aims to give an overview on what has emerged from basic research and clinical approaches on the role of the endocannabinoid system (ECS) in the human lower urinary tract and reproductive tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review article highlights some key data from research into the cannabinoid system and its potential role in the control of micturition, reproductive functions and also dysfunctions of the lower urinary tract.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While basic research findings on the ECS in reproductive tissues (penile erectile tissue, seminal vesicles) have not yet been supplemented by data from trials addressing clinical conditions such as erectile dysfunction (ED) and ejaculatory disorders (for example, premature ejaculation), targeting the ECS has been suggested as a pharmacological approach to treat disorders of bladder filling and storage functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite some preclinical data may favor a role of receptors, ligands and regulatory proteins of the ECS in the LUT, additional clinical evidence is required in order to support a significance of a modulation of the pathways stimulated by cannabinoid molecules in the treatment of dysfunctions of the lower urinary and genital tract.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-06045-x","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T09:12:57Z","timestamp":1765012377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The significance of endocannabinoid receptors and endocannabinoids in the lower urinary and genital tract"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7169-0385","authenticated-orcid":false,"given":"Stefan","family":"\u00dcckert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Hedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tsikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"6045_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0083-6729(09)81004-2","volume":"81","author":"CE Goodfellow","year":"2009","unstructured":"Goodfellow CE, Glass M (2009) Anandamide receptor signal transduction. Vitam Horm 81:79\u2013110","journal-title":"Vitam Horm"},{"key":"6045_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.eururo.2008.12.024","volume":"57","author":"C Gratzke","year":"2010","unstructured":"Gratzke C, Christ GJ, Stief CG, Andersson KE, Hedlund P (2010) Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. Eur Urol 57:342\u2013348","journal-title":"Eur Urol"},{"key":"6045_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.eururo.2008.04.042","volume":"55","author":"C Gratzke","year":"2009","unstructured":"Gratzke C, Streng T, Waldkirch E, Sigl K, Stief CG, Andersson KE, Hedlund P (2009) Transient receptor potential A1 (TRPA1) activity in the human urethra - evidence for a functional role for TRPA1 in the outflow region. Eur Urol 55:696\u2013704","journal-title":"Eur Urol"},{"key":"6045_CR4","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.urology.2008.03.044","volume":"72","author":"MH Hayn","year":"2008","unstructured":"Hayn MH, Ballesteros I, de Miguel F, Coyle CH, Tyagi S, Yoshimura N, Chancellor MB, Tyagi P (2008) Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology 72:1174\u20131178","journal-title":"Urology"},{"key":"6045_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","volume":"60","author":"V di Marzo","year":"2009","unstructured":"di Marzo V (2009) The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60:77\u201384","journal-title":"Pharmacol Res"},{"key":"6045_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/nau.22442","volume":"33","author":"P Hedlund","year":"2014","unstructured":"Hedlund P (2014) Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction. Neurourol Urodyn 33:46\u201353","journal-title":"Neurourol Urodyn"},{"key":"6045_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrurol.2016.110","volume":"13","author":"P Hedlund","year":"2016","unstructured":"Hedlund P, Gratzke C (2016) The endocannabinoid system - a target for the treatment of LUTS? Nat Rev Urol 13:463\u2013470","journal-title":"Nat Rev Urol"},{"key":"6045_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.708989","volume":"12","author":"S Christie","year":"2021","unstructured":"Christie S, Brookes S, Zagorodnyuk V (2021) Endocannabinoids in bladder sensory mechanisms in health and diseases. Front Pharmacol 12:708989","journal-title":"Front Pharmacol"},{"key":"6045_CR9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/sj.bjp.0703229","volume":"129","author":"S Martin","year":"2000","unstructured":"Martin S, Luong A, Welsh J, Eglen M, Martin R, MacLenna J (2000) Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br J Pharmacol 129:1707\u20131715","journal-title":"Br J Pharmacol"},{"key":"6045_CR10","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.juro.2008.11.079","volume":"181","author":"C Gratzke","year":"2009","unstructured":"Gratzke C, Streng T, Park A, Christ G, Stief CG, Hedlund P, Andersson KE (2009) Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol 181:1939\u20131948","journal-title":"J Urol"},{"key":"6045_CR11","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.juro.2008.11.078","volume":"181","author":"V Tyagi","year":"2009","unstructured":"Tyagi V, Philips BJ, Su R, Smaldone MC, Erickson VL, Chancellor MB, Yoshimura N, Tyagi P (2009) Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 181:1932\u20131938","journal-title":"J Urol"},{"key":"6045_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.eururo.2010.02.027","volume":"57","author":"C Gratzke","year":"2010","unstructured":"Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE (2010) Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol 57:1093\u20131100","journal-title":"Eur Urol"},{"key":"6045_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00429-012-0425-2","volume":"218","author":"G Veress","year":"2013","unstructured":"Veress G, Meszar Z, Muszil D, Avelino A, Matesz K, Mackie K, Nagy I (2013) Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons. Brain Struct Funct 218:733\u2013750","journal-title":"Brain Struct Funct"},{"key":"6045_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/24740527.2023.2264895","volume":"7","author":"J Parnell","year":"2023","unstructured":"Parnell J, Martin N, Dedek A, Rudyk C, Landrigan J, Bellavance J, van der Loo S, Tsai EC, Hildebrand ME (2023) Cannabinoid CB1 receptor expression and localization in the dorsal horn of male and female rat and human spinal cord. Can J Pain 7:2264895","journal-title":"Can J Pain"},{"key":"6045_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175624","volume":"945","author":"S Ramsay","year":"2023","unstructured":"Ramsay S, Spencer NJ, Zagorodnyuk V (2023) Endocannabinoids, Anandamide and 2-AG, regulate mechanosensitivity of mucosal afferents in the Guinea pig bladder. Eur J Pharmacol 945:175624","journal-title":"Eur J Pharmacol"},{"key":"6045_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177078","volume":"985","author":"S Ramsay","year":"2024","unstructured":"Ramsay S, Yew WP, Brookes S, Zagorodnyuk VA (2024) Combination of peripherally restricted CB1 and CB2 cannabinoid receptor agonists reduces bladder afferent sensitisation in cystitis. Eur J Pharmacol 985:177078","journal-title":"Eur J Pharmacol"},{"key":"6045_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.juro.2014.04.008","volume":"192","author":"N Aizawa","year":"2014","unstructured":"Aizawa N, Hedlund P, F\u00fcllhase C, Ito H, Homma Y, Igawa Y (2014) Inhibition of peripheral FAAH depresses activities of bladder mechano-sensitive nerve fibers of the rat. J Urol 192:956\u2013963","journal-title":"J Urol"},{"key":"6045_CR18","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.juro.2012.11.165","volume":"189","author":"C F\u00fcllhase","year":"2013","unstructured":"F\u00fcllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, Gratzke C, Bettiga A, Stief CG, Andersson KE, Hedlund P (2013) Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats. J Urol 189:2364\u20132370","journal-title":"J Urol"},{"key":"6045_CR19","doi-asserted-by":"publisher","first-page":"1514e15","DOI":"10.1016\/j.urology.2009.12.051","volume":"75","author":"G Mukerji","year":"2010","unstructured":"Mukerji G, Yiangou Y, Agarwal SK, Anand P (2010) Increased cannabinoid receptor 1- immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology 75:1514e15-1514e20","journal-title":"Urology"},{"key":"6045_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010019","volume":"12","author":"S Sultana","year":"2021","unstructured":"Sultana S, Berger G, Lehmann C (2021) Components of the endogenous cannabinoid system as potential biomarkers for interstitial cystitis\/bladder pain syndrome. Diagnostics 12:19","journal-title":"Diagnostics"},{"key":"6045_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","volume":"17","author":"RM Freeman","year":"2006","unstructured":"Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J (2006) The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multi-centre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 17:636\u2013641","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"6045_CR22","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/1352458510378020","volume":"16","author":"RB Kavia","year":"2010","unstructured":"Kavia RB, de Ridder D, Constantinescu CS, Stott CG, Fowler CJ (2010) Randomized controlled trial of SATIVEX to treat detrusor overactivity in multiple sclerosis. Mult Scler 16:1349\u20131359","journal-title":"Mult Scler"},{"key":"6045_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10072-017-3148-6","volume":"39","author":"GT Maniscalco","year":"2018","unstructured":"Maniscalco GT, Aponte R, Bruzzese D, Guarcello G, Manzo V, Napolitano M, Moreggia O, Chiariello F, Florio C (2018) THC\/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study. Neurol Sci 39:97\u2013102","journal-title":"Neurol Sci"},{"key":"6045_CR24","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2023-10-1","volume":"13","author":"N Garde","year":"2024","unstructured":"Garde N, Heibel M (2024) Effect of nabiximols oromucosal spray (SATIVEX\u00ae) on symptoms associated with multiple sclerosis-related spasticity: a case series. Drugs Context 13:2023-10-1","journal-title":"Drugs Context"},{"key":"6045_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25214930","volume":"25","author":"E Jones","year":"2020","unstructured":"Jones E, Vlachou SA (2020) Critical review of the role of the cannabinoid compounds \u22069-tetrahydrocannabinol (\u22069-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment. Molecules 25:4930","journal-title":"Molecules"},{"key":"6045_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrurol.2011.130","volume":"8","author":"I D\u00edaz-Laviada","year":"2011","unstructured":"D\u00edaz-Laviada I (2011) The endocannabinoid system in prostate cancer. Nat Rev Urol 8:553\u2013561","journal-title":"Nat Rev Urol"},{"key":"6045_CR27","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-04-3410","volume":"65","author":"S Sarfaraz","year":"2005","unstructured":"Sarfaraz S, Afaq F, Adhami VM, Mukhtar H (2005) Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 65:1635\u20131641","journal-title":"Cancer Res"},{"key":"6045_CR28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/or.2015.3746","volume":"33","author":"O Orellana-Serradell","year":"2015","unstructured":"Orellana-Serradell O, Poblete CE, Sanchez C, Castell\u00f3n EA, Gallegos I, Huidobro C, Llanos MN, Contreras HR (2015) Proapoptotic effect of endocannabinoids in prostate cancer cells. Oncol Rep 33:1599\u20131608","journal-title":"Oncol Rep"},{"key":"6045_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02561-4","volume":"20","author":"J Huang","year":"2022","unstructured":"Huang J, Zhao B, Weinstein SJ, Albanes D, Mondul AM (2022) Metabolomic profile of prostate cancer-specific survival among 1812 Finnish men. BMC Med 20:362","journal-title":"BMC Med"},{"key":"6045_CR30","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.3390\/cancers12113275","volume":"12","author":"E Moreno","year":"2020","unstructured":"Moreno E, Cavic M, Krivokuca A, Canela EI (2020) The interplay between cancer biology and the endocannabinoid system - Significance for cancer risk, prognosis and response to treatment. Cancers (Basel) 12:3275","journal-title":"Cancers (Basel)"},{"key":"6045_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/can.2021.0045","volume":"7","author":"J Guggisberg","year":"2022","unstructured":"Guggisberg J, Schumacher M, Gilmore G, Zylla DM (2022) Cannabis as an anticancer agent: a review of clinical data and assessment of case reports. Cannabis Cannabinoid Res 7:24\u201333","journal-title":"Cannabis Cannabinoid Res"},{"key":"6045_CR32","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00345-019-02647-4","volume":"37","author":"S Kira","year":"2019","unstructured":"Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Sawada N, Andersson KE, Takeda M (2019) Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men. World J Urol 37:2199\u20132205","journal-title":"World J Urol"},{"key":"6045_CR33","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.eururo.2009.08.019","volume":"57","author":"C Gratzke","year":"2010","unstructured":"Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund (2010) Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells. Eur Urol 57:902\u2013910","journal-title":"Eur Urol"},{"key":"6045_CR34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.17305\/bb.2023.9173","volume":"23","author":"BG Eid","year":"2023","unstructured":"Eid BG, Neamatallah T, Binmahfouz LS, Bagher AM, Alamoudi AJ, Aldawsari HM, Hanafy A, Hasan A, el-Bassossy HM, Abdel-Naim AB, Vemuri K, Makriyannis A (2023) Effects of the CB1 receptor antagonists AM 6545 and AM 4113 on metabolic syndrome-induced prostatic hyperplasia in rats. Biomol Biomed 23:1069\u20131078","journal-title":"Biomol Biomed"},{"key":"6045_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.urology.2017.02.029","volume":"103","author":"FME Wagenlehner","year":"2017","unstructured":"Wagenlehner FME, van Till JWO, Houbiers JGA, Martina RV, Cerneus DP, Melis JHJ, Majek A, Vjaters E, Urban M, Ramonas H, Shoskes DA, Nickel JC (2017) Fatty acid amide hydrolase inhibitor treatment in men with chronic postatitis\/chronic pelvic pain syndrome: an adaptive double-blind, randomized controlled trial. UROLOGY 103:191\u2013197","journal-title":"UROLOGY"},{"key":"6045_CR36","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S1359-6446(05)03596-8","volume":"10","author":"IA Abdel-Hamid","year":"2005","unstructured":"Abdel-Hamid IA (2005) Can smooth muscle represent a useful target for the treatment of rapid ejaculation? Drug Discov Today 10:1459\u20131466","journal-title":"Drug Discov Today"},{"key":"6045_CR37","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/S0022-5347(05)64146-8","volume":"168","author":"MD Waldinger","year":"2002","unstructured":"Waldinger MD (2002) The neurobiological approach to premature ejaculation. J Urol 168:2359\u20132367","journal-title":"J Urol"},{"issue":"Suppl 4","key":"6045_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1743-6109.2006.00305.x","volume":"3","author":"CF Donatucci","year":"2006","unstructured":"Donatucci CF (2006) Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med 3(Suppl 4):303\u2013308","journal-title":"J Sex Med"},{"key":"6045_CR39","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/S0022-5347(01)66861-7","volume":"154","author":"B Matitiahu","year":"1995","unstructured":"Matitiahu B, Keresteci AG, Koren G (1995) Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol 154:1360\u20131361","journal-title":"J Urol"},{"key":"6045_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1743-6109.2008.00831.x","volume":"5","author":"H Sadeghi-Nejad","year":"2008","unstructured":"Sadeghi-Nejad H, Watson R (2008) Premature ejaculation: current medical treatment and new directions. J Sex Med (JSM) 5:1037\u20131050","journal-title":"J Sex Med (JSM)"},{"key":"6045_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","volume":"55","author":"J Buvat","year":"2009","unstructured":"Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F (2009) Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 55:957\u2013967","journal-title":"Eur Urol"},{"key":"6045_CR42","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.eururo.2007.08.005","volume":"52","author":"J Chen","year":"2007","unstructured":"Chen J, Keren-Paz G, Bar-Yosef Y, Matzkin H (2007) The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data. Eur Urol 52:1331\u20131339","journal-title":"Eur Urol"},{"key":"6045_CR43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/jsm.12866","volume":"12","author":"G Rodr\u00edguez-Manzo","year":"2015","unstructured":"Rodr\u00edguez-Manzo G, Canseco-Alba A (2015) Anandamide reduces the ejaculatory threshold of sexually sluggish male rats: possible relevance for human lifelong delayed ejaculation disorder. J Sex Med 12:1128\u20131135","journal-title":"J Sex Med"},{"key":"6045_CR44","doi-asserted-by":"publisher","first-page":"e12875","DOI":"10.1111\/and.12875","volume":"50","author":"S \u00dcckert","year":"2018","unstructured":"\u00dcckert S, la Croce G, Bettig A, Albrecht K, Buono R, Benigni F, Kuczyk MA, Hedlund (2018) Expression and distribution of key proteins of the endocannabinoid system (ECS) in the human seminal vesicles. ANDROLOGIA 50:e12875","journal-title":"ANDROLOGIA"},{"key":"6045_CR45","doi-asserted-by":"publisher","first-page":"e47704","DOI":"10.1371\/journal.pone.0047704","volume":"7","author":"SE Lewis","year":"2012","unstructured":"Lewis SE, Rapino C, di Tommaso M, Pucci M, Battista N, Paro R, Simon L, Lutton D, Maccarrone M (2012) Differences in the endocannabinoid system of sperm from fertile and infertile men. PLoS ONE 7:e47704","journal-title":"PLoS ONE"},{"key":"6045_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/sj.bjp.0703930","volume":"32","author":"A Christopoulos","year":"2001","unstructured":"Christopoulos A, Coles P, Lay L, Lew MJ, Angus JA (2001) Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens. Br J Pharmacol 32:1281\u20131291","journal-title":"Br J Pharmacol"},{"key":"6045_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/fcp.13008","volume":"38","author":"Y Okcay","year":"2024","unstructured":"Okcay Y, Onal Sis C, Ozpolat MC, Rumanli Z, Ulusoy KG, Yildiz O, Vural IM (2024) The relaxation effect of endocannabinoid Anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms. Fundam Clin Pharmacol 38:967\u2013977","journal-title":"Fundam Clin Pharmacol"},{"key":"6045_CR48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/edrv.22.3.0430","volume":"22","author":"FR Kandeel","year":"2001","unstructured":"Kandeel FR, Koussa VKT, Swerdloff RS (2001) Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev 22:342\u2013388","journal-title":"Endocr Rev"},{"issue":"Suppl","key":"6045_CR49","first-page":"S6","volume":"170","author":"KE Andersson","year":"2003","unstructured":"Andersson KE (2003) Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol 170(Suppl):S6\u2013S14","journal-title":"J Urol"},{"key":"6045_CR50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1743-6109.2005.00080.x","volume":"2","author":"CS Lin","year":"2005","unstructured":"Lin CS, Lin G, Lue TF (2005) Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2:478\u2013491","journal-title":"J Sex Med"},{"issue":"Suppl 4","key":"6045_CR51","first-page":"S11","volume":"104","author":"DO Sussman","year":"2004","unstructured":"Sussman DO (2004) Pharmacokinetics, pharmacodynamics and efficacy of phosphodiesterase type 5 inhibitors. J Am Osteopath Assoc 104(Suppl 4):S11\u2013S15","journal-title":"J Am Osteopath Assoc"},{"key":"6045_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092987","volume":"9","author":"GT Kedia","year":"2020","unstructured":"Kedia GT, \u00dcckert S, Tsikas D, Becker AJ, Kuczyk MA, Bannowsky A (2020) The use of vasoactive drugs in the treatment of male erectile dysfunction: current concepts. J Clin Med 9:E2987","journal-title":"J Clin Med"},{"key":"6045_CR53","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0022-5347(17)51174-X","volume":"130","author":"J Gu","year":"1983","unstructured":"Gu J, Polak JM, Prober L, Islam KN, Marangos PJ, Mina S, Adrian TE, McGregor GP, O\u2019Shaughnessy DJ, Bloom SR (1983) Peptidergic innervation of the human male genital tract. J Urol 130:386\u2013391","journal-title":"J Urol"},{"key":"6045_CR54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1748-1716.1985.tb07677.x","volume":"124","author":"H Hedlund","year":"1985","unstructured":"Hedlund H, Andersson KE (1985) Effects of some peptides on isolated human penile erectile tissue and cavernous artery. Acta Physiol Scand 124:413\u2013419","journal-title":"Acta Physiol Scand"},{"key":"6045_CR55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2006.06.002","volume":"544","author":"M Ghasemi","year":"2006","unstructured":"Ghasemi M, Sadeghipour H, Mani AR, Tavakoli S, Hajrasouliha AR, Ebrahimi F, Dehpour AR (2006) Effect of Anandamide on nonadrenergic, noncholinergic-mediated relaxation of rat corpus cavernosum. Eur J Pharmacol 544:138\u2013145","journal-title":"Eur J Pharmacol"},{"key":"6045_CR56","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1743-6109.2008.01003.x","volume":"6","author":"IM Vural","year":"2009","unstructured":"Vural IM, Ozturk GS, Sarioglu Y (2009) Functional characterization of nonadrenergic, noncholinergic neurotransmitter release via endocannabinoids: an in vitro study in rabbit corpus cavernosum. J Sex Med 6:717\u2013729","journal-title":"J Sex Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06045-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:05:52Z","timestamp":1781622352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06045-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6045"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06045-x","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"26"}}